In recent trading session, Tenaya Therapeutics Inc (NASDAQ:TNYA) saw 0.43 million shares changing hands at last check today with its beta currently measuring 2.85. Company’s recent per share price level of $1.13 trading at $0.01 or 0.89% at last check today assigns it a market valuation of $89.52M. That most recent trading price of TNYA’s stock is at a discount of -520.35% from its 52-week high price of $7.01 and is indicating a premium of 23.89% from its 52-week low price of $0.86.
For Tenaya Therapeutics Inc (TNYA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.31 in the current quarter.
Tenaya Therapeutics Inc (NASDAQ:TNYA) trade information
Upright in the green today for gaining 0.89%, in the last five days TNYA remained trading in the green while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $1.13 price level, adding 8.87% to its value on the day. Tenaya Therapeutics Inc’s shares saw a change of -20.98% in year-to-date performance and have moved 25.91% in past 5-day. Tenaya Therapeutics Inc (NASDAQ:TNYA) showed a performance of -13.08% in past 30-days.
Tenaya Therapeutics Inc (TNYA) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -27.43% during past 5 years. In 2025, company’s earnings growth rate is likely to be around 19.60% while estimates for its earnings growth in next 5 years are of 8.78%.
Tenaya Therapeutics Inc (NASDAQ:TNYA)’s Major holders
COLUMN GROUP LLC is the top institutional holder at TNYA for having 9.4 million shares of worth $29.14 million. And as of 2024-06-30, it was holding 11.6078 of the company’s outstanding shares.
The second largest institutional holder is RA CAPITAL MANAGEMENT, L.P., which was holding about 7.62 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.4124 of outstanding shares, having a total worth of $23.63 million.
On the other hand, Price (T.Rowe) New Horizons Fund and Vanguard Total Stock Market Index Fund are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024, the former fund manager was holding 2.1 shares of worth $2.39 million or 2.65% of the total outstanding shares. The later fund manager was in possession of 2.06 shares on Sep 30, 2024, making its stake of worth around $2.35 million in the company or a holder of 2.61% of company’s stock.
